ATRA

Atara Biotherapeutics Inc

Jun 23 • 04:00PM ET

11.16

+0.55 5.18 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CLLS FATE ALLO CHRS ALEC ZNTL CCCC REPL ELDN LENZ

| Held by: VTI VXF IWC DCOR DFAC BTEC DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.88	Insider Own	33.40%	Shs Outstand	8.51M	Perf Week	12.05%
Market Cap	100.56M	Forward P/E	12.47	EPS next Y	0.90	Insider Trans	3.46%	Shs Float	6.00M	Perf Month	19.49%
Enterprise Value	143.76M	PEG	-	EPS next Q	-0.32	Inst Own	48.40%	Short Float	8.07%	Perf Quarter	130.34%
Income	-9.47M	P/S	4.35	EPS this Y	-150.39%	Inst Trans	1.03%	Short Ratio	0.35	Perf Half Y	-35.23%
Sales	23.14M	P/B	-	EPS next Y	169.11%	ROA	-23.08%	Short Interest	0.48M	Perf YTD	-38.31%
Book/sh	-4.38	P/C	12.03	EPS next 5Y	-	ROE	-	52W High	19.15 -41.71%	Perf Year	41.62%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	- -	ROIC	-75.60%	52W Low	3.92 184.69%	Perf 3Y	-74.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.85% -	Gross Margin	96.12%	Volatility	9.19% 8.77%	Perf 5Y	-97.12%
Dividend TTM	-	EV/Sales	6.21	EPS Y/Y TTM	76.14%	Oper. Margin	-26.42%	ATR (14)	0.89	Perf 10Y	-97.98%
Dividend Ex-Date	-	Quick Ratio	2.16	Sales Y/Y TTM	-88.41%	Profit Margin	-40.91%	RSI (14)	64.71	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-108.40%	SMA20	9.90%	Beta	0.10	Target Price	13.67
Payout	0.00%	Debt/Eq	-	Sales Q/Q	-99.47%	SMA50	37.31%	Rel Volume	0.07	Prev Close	10.61
Employees	14	LT Debt/Eq	-	Earnings	May 12 AMC	SMA200	11.84%	Avg Volume	1.40M	Price	11.16
IPO	Oct 16, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	11.99% -82.21%	Trades		Volume	103,981	Change	5.18%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)